menu
    • menu
    [{"orgOrder":0,"company":"Read-Gene S.A.","sponsor":"National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"POLAND","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2019","type":"Inapplicable","leadProduct":"Selenium","moa":"Selenoprotein","graph1":"Oncology","graph2":"Undisclosed","graph3":"Read-Gene S.A.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Read-Gene S.A. \/ National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.","highestDevelopmentStatusID":"1","companyTruncated":"Read-Gene S.A. \/ National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A."},{"orgOrder":0,"company":"University Hospital, Linkoeping","sponsor":"Ostergotland County Council | The Swedish Research Council | Pharma Nord","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"SWEDEN","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2011","type":"Inapplicable","leadProduct":"Selenium","moa":"Selenoprotein","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"University Hospital, Linkoeping","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University Hospital, Linkoeping \/ Ostergotland County Council | The Swedish Research Council | Pharma Nord","highestDevelopmentStatusID":"1","companyTruncated":"University Hospital, Linkoeping \/ Ostergotland County Council | The Swedish Research Council | Pharma Nord"},{"orgOrder":0,"company":"Newcastle University","sponsor":"Fera Science Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"UNITED KINGDOM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2018","type":"Inapplicable","leadProduct":"Selenium","moa":"Selenoprotein","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Newcastle University","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Newcastle University \/ Fera Science Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Newcastle University \/ Fera Science Ltd."},{"orgOrder":0,"company":"Canadian College of Naturopathic Medicine","sponsor":"Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CANADA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2011","type":"Inapplicable","leadProduct":"Selenium","moa":"Selenoprotein","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Canadian College of Naturopathic Medicine","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Canadian College of Naturopathic Medicine \/ Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre","highestDevelopmentStatusID":"10","companyTruncated":"Canadian College of Naturopathic Medicine \/ Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre"},{"orgOrder":0,"company":"Boryung Pharmaceutical Co., Ltd","sponsor":"Biosyn | Boryung Pharmaceutical Co., Ltd","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"SOUTH KOREA","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2012","type":"Inapplicable","leadProduct":"Selenium","moa":"Selenoprotein","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Boryung Pharmaceutical Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Boryung Pharmaceutical Co., Ltd \/ Biosyn | Boryung Pharmaceutical Co., Ltd","highestDevelopmentStatusID":"8","companyTruncated":"Boryung Pharmaceutical Co., Ltd \/ Biosyn | Boryung Pharmaceutical Co., Ltd"},{"orgOrder":0,"company":"Netherlands Heart Institute","sponsor":"University Medical Center Groningen | ZonMw | Hartstichting | Pharma Nord | WCN (Werkgroep Cardiologische centra Nederland)","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"NETHERLANDS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2025","type":"Inapplicable","leadProduct":"Selenium","moa":"Survivin","graph1":"Cardiology\/Vascular Diseases","graph2":"Phase III","graph3":"Netherlands Heart Institute","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Netherlands Heart Institute \/ University Medical Center Groningen | ZonMw | Hartstichting | Pharma Nord | WCN (Werkgroep Cardiologische centra Nederland)","highestDevelopmentStatusID":"10","companyTruncated":"Netherlands Heart Institute \/ University Medical Center Groningen | ZonMw | Hartstichting | Pharma Nord | WCN (Werkgroep Cardiologische centra Nederland)"}]

    Find Clinical Drug Pipeline Developments & Deals for Selenium

    Menu

    Selenium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Netherlands Heart Institute

                            Country arrow
                            IPPE
                            Not Confirmed

                            Netherlands Heart Institute

                            Country arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Phase III

                            Sponsor : University Medical Center Groningen | ZonMw | Hartstichting | Pharma Nord | WCN (Werkgroep Cardiologische centra Nederland)

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Seleni...

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Heart Failure.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            November 18, 2025

                            Lead Product(s) : Selenium

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Phase III

                            Sponsor : University Medical Center Groningen | ZonMw | Hartstichting | Pharma Nord | WCN (Werkgroep Cardiologische centra Nederland)

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Read-Gene S.A.

                            Country arrow
                            IPPE
                            Not Confirmed

                            Read-Gene S.A.

                            Country arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium

                            Therapeutic Area : Oncology

                            Study Phase : Undisclosed

                            Sponsor : National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Breast Neoplasms.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            July 10, 2019

                            Lead Product(s) : Selenium

                            Therapeutic Area : Oncology

                            Highest Development Status : Undisclosed

                            Sponsor : National Center for Research and Development, Poland | IQ Pharma S.A. | West Pomeranian University of Technology | Vipharm S.A.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Newcastle University

                            Country arrow
                            IPPE
                            Not Confirmed

                            Newcastle University

                            Country arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : Fera Science Ltd.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Investigating the Sensory Attributes of Selenium-fortified Biscuits and Their Effects on Selenium-status

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            December 10, 2018

                            Lead Product(s) : Selenium

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : Fera Science Ltd.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Boryung Pharmaceutical Co., Ltd

                            South Korea arrow
                            IPPE
                            Not Confirmed

                            Boryung Pharmaceutical Co., Ltd

                            South Korea arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II

                            Sponsor : Biosyn | Boryung Pharmaceutical Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Sepsis.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            May 18, 2012

                            Lead Product(s) : Selenium

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II

                            Sponsor : Biosyn | Boryung Pharmaceutical Co., Ltd

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            University Hospital, Linkoeping

                            Country arrow
                            IPPE
                            Not Confirmed

                            University Hospital, Linkoeping

                            Country arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium,Ubiquinon Q10

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Study Phase : Undisclosed

                            Sponsor : Ostergotland County Council | The Swedish Research Council | Pharma Nord

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Intervention With Selenium and Q10 on Cardiovascular Mortality and Cardiac Function in the Elderly Population ...

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Cardiovascular Diseases.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            September 30, 2011

                            Lead Product(s) : Selenium,Ubiquinon Q10

                            Therapeutic Area : Cardiology/Vascular Diseases

                            Highest Development Status : Undisclosed

                            Sponsor : Ostergotland County Council | The Swedish Research Council | Pharma Nord

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            Canadian College of Naturopathic Medicine

                            Country arrow
                            IPPE
                            Not Confirmed

                            Canadian College of Naturopathic Medicine

                            Country arrow
                            IPPE
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Selenium

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Rwanda Selenium Supplementation Clinical Trial

                            Details : Selenium is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of HIV Infections.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            April 04, 2011

                            Lead Product(s) : Selenium

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Global Benefit Canada | University of Ottawa | Wilfrid Laurier University | Kibagabaga District Hospital | Kinyinya Health Centre

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.